Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 1/2007

01-02-2007 | Erratum

Historical estimation of diesel exhaust exposure in a cohort study of U.S. railroad workers and lung cancer

Authors: Francine Laden, Jaime E. Hart, Alan Eschenroeder, Thomas J. Smith, Eric Garshick

Published in: Cancer Causes & Control | Issue 1/2007

Login to get access

Excerpt

The units for the Emission Adjustment Factor (EAF) are g/h, as stated in the equation on page 913, paragraph 2. They were incorrectly noted as μg/h in the following places: page 913, paragraph 3; Table 4; and Figure 2. …
Metadata
Title
Historical estimation of diesel exhaust exposure in a cohort study of U.S. railroad workers and lung cancer
Authors
Francine Laden
Jaime E. Hart
Alan Eschenroeder
Thomas J. Smith
Eric Garshick
Publication date
01-02-2007
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 1/2007
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-006-9020-2

Other articles of this Issue 1/2007

Cancer Causes & Control 1/2007 Go to the issue

OriginalPaper

Serum organochlorines and breast cancer: a case–control study among African-American women

Editorial

Transient caloric restriction and cancer risk (The Netherlands)

Original Paper

Meat and dairy consumption and subsequent risk of prostate cancer in a US cohort study

Original Paper

Evaluation of ecological and in vitro effects of boron on prostate cancer risk (United States)

Original Paper

An evaluation of spatial and multivariate covariance among childhood cancer histotypes in Texas (United States)

Original Paper

Tools for health: the efficacy of a tailored intervention targeted for construction laborers
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits